Hospital Universitario Quiron Madrid

Madrid 28223

1 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, Chronic Pain, Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations

Studies at this site

• Patient Retrospective Outcomes (PRO) — Recruiting now
• Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early